21 Jun 2024
12:00 AM
AGM
Announcement Date: 21 Jun, 2024
18 Oct 2024
12:00 AM
Board Meeting
Agenda : Audited Result
9 May 2024
12:00 AM
Dividend
Dividend Amount: 11
Record Date: 15 Jul, 2024
The authorised ANDA is a therapeutic equivalent of the reference-listed drug (RLD), Corlanor tablets, in the same 5 mg and 7.5 mg dosages.
These medications are also used to treat chronic stable angina and angina induced by coronary artery spasm.
Alembic Pharmaceuticals continues to grow its footprint in the US, with this approval contributing to its robust portfolio of generic medications.
The business stated that the authorised ANDA is therapeutically similar to the reference-listed drug product (RLD) Lastacaft Solution.
The approved Lamotrigine Extended-Release tablets are therapeutic equivalents of GlaxoSmithKline's Lamictal XR, with strengths of 200 mg, 250 mg, and 300 mg.
Alembic Pharmaceuticals has got the final approval from USFDA for Dabigatran Etexilate Capsules, 110 mg.
Alembic has 210 ANDA approvals from the USFDA, including 182 final approvals and 28 tentative clearances.
This certification allows a company to apply for approval of a generic drug before the patents of the brand-name drug expire.
Here are some of the stocks that may see significant price movement today: HCL Technologies, Lupin, Piramal Pharma, etc.
Here are some of the stocks that may see significant price movement today: SBI, Sula Vineyards, Zydus Lifesciences, Kesoram Industries, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice
